398 related articles for article (PubMed ID: 11757403)
1. [Susceptibility to macrolide antibiotics of Bordetella pertussis and Bordetella parapertussis strains isolated from whooping cough patients in 1968 and in 1997-99].
Chodorowska M; Kuklińska D; Tyski S
Med Dosw Mikrobiol; 2001; 53(1):39-43. PubMed ID: 11757403
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine).
Hoppe JE; Bryskier A
Antimicrob Agents Chemother; 1998 Apr; 42(4):965-6. PubMed ID: 9559823
[TBL] [Abstract][Full Text] [Related]
3. Activity of new macrolides against Bordetella pertussis and Bordetella parapertussis.
Hoppe JE; Eichhorn A
Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):653-4. PubMed ID: 2550234
[TBL] [Abstract][Full Text] [Related]
4. Trends in the Minimum Inhibitory Concentrations of Erythromycin, Clarithromycin, Azithromycin, Ciprofloxacin, and Trimethoprim/Sulfamethoxazole for Strains of Bordetella pertussis isolated in the Czech Republic in 1967-2015.
Jakubů V; Zavadilová J; Fabiánová K; Urbášková P
Cent Eur J Public Health; 2017 Dec; 25(4):282-286. PubMed ID: 29346850
[TBL] [Abstract][Full Text] [Related]
5. Minimum inhibitory concentrations of erythromycin and other antibiotics for Czech strains of Bordetella pertussis.
Jakubů V; Zavadilová J; Fabiánová K; Urbášková P
Epidemiol Mikrobiol Imunol; 2015 Mar; 64(1):12-5. PubMed ID: 25872990
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of Bordetella pertussis and Bordetella parapertussis to 24 antibiotics.
Hoppe JE; Haug A; Botzenhart K
Chemotherapy; 1987; 33(4):250-4. PubMed ID: 2886295
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity and clinical efficacy of macrolides, cefoperazone-sulbactam and piperacillin/piperacillin-tazobactam against Bordetella pertussis and the clinical manifestations in pertussis patients due to these isolates: A single-centre study in Zhejiang Province, China.
Hua CZ; Wang HJ; Zhang Z; Tao XF; Li JP; Mi YM; Tang LF; Chen ZM
J Glob Antimicrob Resist; 2019 Sep; 18():47-51. PubMed ID: 30710647
[TBL] [Abstract][Full Text] [Related]
8. Mixed outbreak of Bordetella pertussis and Bordetella parapertussis in an apartment house.
Iwata S; Aoyama T; Goto A; Iwai H; Sato Y; Akita H; Murase Y; Oikawa T; Iwata T; Kusano S
Dev Biol Stand; 1991; 73():333-41. PubMed ID: 1778328
[TBL] [Abstract][Full Text] [Related]
9. Effect of Macrolides and β-lactams on Clearance of Bordetella pertussis in the Nasopharynx in Children With Whooping Cough.
Mi YM; Hua CZ; Fang C; Liu JJ; Xie YP; Lin LN; Wang GL
Pediatr Infect Dis J; 2021 Feb; 40(2):87-90. PubMed ID: 33021592
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Etest and agar dilution for testing the activity of three macrolides against Bordetella parapertussis.
Hoppe JE; Tschirner T
Diagn Microbiol Infect Dis; 1997 May; 28(1):49-51. PubMed ID: 9218920
[TBL] [Abstract][Full Text] [Related]
11. [In vitro activity of roxithromycin, new semisynthetic macrolide against obligate anaerobes].
Dubreuil L; Devos J; Romond C; Bryskier A
Pathol Biol (Paris); 1986 May; 34(5):440-4. PubMed ID: 3534717
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of gemifloxacin and other antimicrobial agents against isolates of Bordetella pertussis and Bordetella parapertussis.
Mortensen JE; Rodgers GL
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():47-9. PubMed ID: 10824032
[TBL] [Abstract][Full Text] [Related]
13. In vitro activities of various antimicrobials against Brucella melitensis strains in the Aegean region in Turkey.
Yamazhan T; Aydemir S; Tünger A; Serter D; Gökengin D
Med Princ Pract; 2005; 14(6):413-6. PubMed ID: 16220015
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to seven fluoroquinolones.
Hoppe JE; Simon CG
Antimicrob Agents Chemother; 1990 Nov; 34(11):2287-8. PubMed ID: 2073123
[TBL] [Abstract][Full Text] [Related]
15. Genomic and transcriptomic variation in Bordetella spp. following induction of erythromycin resistance.
Fong W; Timms V; Sim E; Pey K; Nguyen T; Sintchenko V
J Antimicrob Chemother; 2022 Oct; 77(11):3016-3025. PubMed ID: 35971665
[TBL] [Abstract][Full Text] [Related]
16. [Macrolide antibiotic resistance rates and phenotypes of group A beta hemolytic streptococci isolated between the years 1999-2000 and 2001-2002].
Senses Z; Baysallar M; Gür D; Doğanci L
Mikrobiyol Bul; 2003 Oct; 37(4):225-34. PubMed ID: 14748258
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of Streptococcus pyogenes to azithromycin, clarithromycin, erythromycin and roxithromycin in vitro.
Van Asselt GJ; Sloos JH; Mouton RP; Van Boven CP; Van de Klundert JA
J Med Microbiol; 1995 Nov; 43(5):386-91. PubMed ID: 7563004
[TBL] [Abstract][Full Text] [Related]
18. The in vitro activity of roxithromycin (RU 28965) compared with four oral antibiotics.
Drabu YJ; Mehtar S; Blakemore PH
Drugs Exp Clin Res; 1987; 13(4):201-3. PubMed ID: 3622250
[TBL] [Abstract][Full Text] [Related]
19. Whooping cough in Pakistan: Bordetella pertussis vs Bordetella parapertussis in 2005-2009.
Bokhari H; Said F; Syed MA; Mughal A; Kazi YF; Heuvelman K; Mooi FR
Scand J Infect Dis; 2011 Oct; 43(10):818-20. PubMed ID: 21563881
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility testing of Finnish Bordetella pertussis isolates collected during 2006-2017.
Lönnqvist E; Barkoff AM; Mertsola J; He Q
J Glob Antimicrob Resist; 2018 Sep; 14():12-16. PubMed ID: 29486357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
